| Aug 1 |
Alnylam Pharmaceuticals (ALNY) Q2 Earnings and Revenues Beat Estimates
|
| Aug 1 |
Alnylam: Q2 Earnings Snapshot
|
| Aug 1 |
Alnylam Pharmaceuticals Non-GAAP EPS of $0.56, revenue of $659.83M beats by $215.67M
|
| Aug 1 |
Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock
|
| Aug 1 |
Alnylam Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Period Activity
|
| Jul 31 |
Alnylam Pharmaceuticals Q2 2024 Earnings Preview
|
| Jul 30 |
Seeking Clues to Alnylam (ALNY) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
|
| Jul 29 |
Analysts Estimate CRISPR Therapeutics AG (CRSP) to Report a Decline in Earnings: What to Look Out for
|
| Jul 25 |
Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
| Jul 22 |
Market Sentiment Around Loss-Making Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
|
